30 filings
8-K
APGN
Apexigen Inc
23 Aug 23
Completion of Acquisition or Disposition of Assets
9:01am
8-K
APGN
Apexigen Inc
22 Aug 23
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
APGN
Apexigen Inc
18 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
APGN
Apexigen Inc
15 Aug 23
Other Events
4:31pm
8-K
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
8-K
gepi ck98v29cjxq
12 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
8-K
x2kmgeb
27 Feb 23
Apexigen Announces Review of Strategic Alternatives and Restructuring
4:31pm
8-K
hxr1r
14 Feb 23
Departure of Directors or Certain Officers
6:25am
8-K
lspouvp
1 Feb 23
Unregistered Sales of Equity Securities
4:06pm
8-K
cew 8rux2
25 Jan 23
Apexigen Announces Approximately $2.8 Million
4:02pm
8-K
f777i5v 3wgi3
14 Nov 22
Changes in Registrant's Certifying Accountant
4:07pm
8-K/A
5x1cc6ztssmok 3c813
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
8-K
8pb795
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm
8-K
k63bx
1 Aug 22
Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company
9:15am
8-K
fyp5z9t4l
27 Jul 22
Brookline Capital Acquisition Corp. and Apexigen, Inc. Announce Stockholder Approval of
5:41pm
8-K
eky57ifpomcd24112s
18 Jul 22
Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement
5:11pm
8-K
g0lz0i4b
30 Jun 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7:16am
8-K
qk63tcoipiboah www
27 Jun 22
Other Events
8:00am
8-K
m9mof2
2 Jun 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:01pm
8-K
lbfkgrvihmcruevt8tx0
2 May 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:36pm